XML 59 R47.htm IDEA: XBRL DOCUMENT v3.19.2
Fair Value Measurements (Narrative) (Detail)
$ / shares in Units, shares in Millions
3 Months Ended 6 Months Ended 12 Months Ended
Aug. 02, 2018
USD ($)
Jul. 08, 2016
USD ($)
Jun. 30, 2019
USD ($)
Jun. 30, 2018
USD ($)
Jun. 30, 2019
USD ($)
Jun. 30, 2018
USD ($)
Dec. 31, 2018
USD ($)
Aug. 03, 2018
USD ($)
Jun. 29, 2018
USD ($)
Jul. 09, 2016
USD ($)
Dec. 31, 2015
$ / shares
Dec. 15, 2015
shares
Sep. 18, 2015
USD ($)
Nov. 06, 2014
USD ($)
Jun. 26, 2014
USD ($)
Oct. 18, 2013
USD ($)
Intangible Assets, Net (Excluding Goodwill) [1]     $ 50,449,000   $ 50,449,000   $ 51,319,000                  
Impairment of Intangible Assets, Finite-lived     0 $ 152,330,000 0 $ 152,330,000 152,300,000                  
Investment Owned, at Cost     $ 6,600,000   6,600,000                      
Goodwill and Intangible Asset Impairment         $ 152,300,000                      
Cash payment for purchase of royalty right                           $ 65,600,000    
Purchase of royalty rights $ 20,000,000                              
Reversionary interest period               $ 481,000,000                
Sensitivity range for royalty disclosures     2.50%   2.50%                      
Royalty rights     $ 315,642,000 [1]   $ 315,642,000 [1]   376,510,000 [2]                  
Transfers from level 1 to level 2, amount     0   0   0                  
Transfers from level 2 to level 1, amount     0   0   0                  
Percentage of royalty acquired                           75.00%    
Revenues     (22,526,000) 46,575,000 16,387,000 85,093,000                    
Finite-Lived Intangible Assets, Gross     58,052,000   58,052,000   55,752,000                  
Asset Impairment Charges     $ 0   0   $ 8,200,000                  
Depomed [Member]                                
Cash payment for purchase of royalty right                               $ 240,500,000
Purchase of royalty rights                               241,300,000
Royalty right purchase transaction costs                               $ 800,000
Cash flow model expected royalty sales term     8 years                          
Sensitivity - decrease in fair value from increase in discount rate     $ 22,200,000   22,200,000                      
Sensitivity - increase in fair value from decrease in discount rate     26,300,000   26,300,000                      
Sensitivity to increase or decrease in expected royalty     6,600,000   6,600,000                      
Royalty rights     263,900,000   263,900,000                      
Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount     $ 263,900,000   $ 263,900,000                      
Contractual cap on potential royalty asset multiple         2                      
VB [Member]                                
Purchase of royalty rights                             $ 15,500,000  
Cash flow model expected royalty sales term     9 years                          
Sensitivity - decrease in fair value from increase in discount rate     $ 1,300,000   $ 1,300,000                      
Sensitivity - increase in fair value from decrease in discount rate     1,500,000   1,500,000                      
Sensitivity to increase or decrease in expected royalty     $ 400,000   $ 400,000                      
Long-Duration Contracts, Assumptions by Product and Guarantee, Discount Rate     15.00%   15.00%                      
Royalty rights     $ 14,400,000   $ 14,400,000                      
Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount     $ 14,400,000   $ 14,400,000                      
Contractual cap on potential royalty asset multiple         2.3                      
University of Michigan [Member]                                
Cash flow model expected royalty sales term     3 years                          
Sensitivity - decrease in fair value from increase in discount rate     $ 900,000   $ 900,000                      
Sensitivity - increase in fair value from decrease in discount rate     1,000,000   1,000,000                      
Sensitivity to increase or decrease in expected royalty     $ 600,000   $ 600,000                      
Long-Duration Contracts, Assumptions by Product and Guarantee, Discount Rate     12.80%   12.80%                      
Royalty rights     $ 24,300,000   $ 24,300,000                      
Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount     $ 24,300,000   24,300,000                      
AcelRx [Member]                                
Purchase of royalty rights                         $ 65,000,000      
Cash flow model expected royalty sales term     14 years                          
Sensitivity - decrease in fair value from increase in discount rate     $ 1,200,000   1,200,000                      
Sensitivity - increase in fair value from decrease in discount rate     1,500,000   1,500,000                      
Sensitivity to increase or decrease in expected royalty     $ 300,000   $ 300,000                      
Long-Duration Contracts, Assumptions by Product and Guarantee, Discount Rate     13.40%   13.40%                      
Royalty rights     $ 12,500,000   $ 12,500,000                      
Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount     12,500,000   $ 12,500,000                      
Percentage of royalty acquired                         75.00%      
Percentage of first four milestone payments acquired                         80.00%      
Number of potential milestone royalties                         4      
Contractual cap on potential royalty asset multiple         3                      
Revenues     $ 60,000,000                          
Kybella [Member]                                
Purchase of royalty rights                   $ 9,500,000            
Cash flow model expected royalty sales term     6 years                          
Sensitivity - increase in fair value from decrease in discount rate     $ 100,000   $ 100,000                      
Sensitivity to increase or decrease in expected royalty     $ 100,000   $ 100,000                      
Long-Duration Contracts, Assumptions by Product and Guarantee, Discount Rate     14.40%   14.40%                      
Royalty rights     $ 600,000   $ 600,000                      
Variable Interest Entity, Reporting Entity Involvement, Maximum Loss Exposure, Amount     $ 600,000   $ 600,000                      
Maximum amount of additional funds, upon attainment of milestones   $ 1,000,000                            
Alphaeon [Member]                                
Investment Owned, Balance, Shares | shares                       1.7        
Investment estimated fair value, per share | $ / shares                     $ 3.84          
Noden [Member]                                
Intangible Assets, Net (Excluding Goodwill)       40,100,000   40,100,000                    
Finite-Lived Intangible Assets, Gross       $ 40,100,000   $ 40,100,000     $ 192,500,000              
Minimum [Member] | Depomed [Member]                                
Long-Duration Contracts, Assumptions by Product and Guarantee, Discount Rate     10.00%   10.00%                      
Maximum [Member] | Depomed [Member]                                
Long-Duration Contracts, Assumptions by Product and Guarantee, Discount Rate     24.00%   24.00%                      
[1] unaudited
[2] Note 1